Elon's Next Market Move Could Send Silver Soaring
Every industry Elon Musk touches explodes—from Tesla to SpaceX to AI.
And now, whispers are growing that his next move could be in silver.
Why? Because silver is the lifeblood of EVs, solar panels, and AI tech.
Without it, Tesla, SpaceX, and Starlink don't grow.
Even back in 2022, Musk hinted at Tesla entering the mining industry. And with new policies clearing the way, the timing couldn't be better.
What happens if Elon enters silver?
- Massive supply chain disruptions – Silver demand is already outpacing supply.
- Prices could surge overnight – Even rumors of Musk in silver could send markets flying.
- A historic opportunity – Investors who act before the headlines could be in for a massive windfall.
Smart money is already watching silver closely.
That's why we put together the 2026 Silver Forecast Guide—your roadmap to silver's biggest growth phase yet.
Click Here to Get your Free Copy Before Silver Moves >>
Because once Musk makes a move, the window to act disappears.
These 3 Cash Flow Machines Provide Stability in Uncertain Markets
Author: Nathan Reiff. Posted: 3/6/2026.
Key Points
- Cash flow generation is a key attribute of stable companies, allowing them flexibility to not only maintain operations but also to grow and to return value to shareholders via dividends or buybacks.
- Gilead Sciences and AbbVie are two large biopharma firms with a compelling history of cash flow generation, helping to facilitate continued R&D and pipeline development, among other things.
- Visa converts about half or more of its revenue to free cash flow, capitalizing on its high-margin business to facilitate growth and dividend payments.
- Special Report: [Sponsorship-Ad-6-Format3]
When times get tough for companies, cash flow is a key factor that determines whether they can survive a challenging market. Simply put, if a firm cannot meet near-term obligations with cash on hand, it risks collapse. Equally important, cash flow enables longer-term plans—everything from expansion and acquisitions to strategic returns of shareholder value.
Cash flow is just one of many measures of stock stability, but it may be especially important for investors seeking companies likely to remain steady amid broad market uncertainty in 2026. The three companies below are household names and industry leaders with strong cash-flow histories that support their plans for continued growth.
Strong Free Cash Flow Yield and Commitment to Returning Value to Investors
Buy This Stock Now (Ad)
In 2000, I warned Barron's that a popular dot-com stock was headed for trouble. It dropped 90%. Now I'm making the opposite call on that same company: buy it now. This stock has become the lifeblood of AI data centers, yet almost no one has caught the story. While the media focuses on AI chip wars, they've missed this company's essential role in building out data centers. Their hardware is so critical that a single building uses enough of it to stretch around the world eight times. If you own Nvidia, you might want to pivot. If you missed Nvidia, this is your second chance at the AI data center buildout happening worldwide.
See the under-the-radar play fueling AI data centersAnchored by top-selling drugs for COVID-19, HIV, certain cancers, and other conditions, Gilead Sciences Inc. (NASDAQ: GILD) is one of the largest biopharma firms available to investors. The company generates compelling free cash flow relative to its share price—it has a free cash flow yield of around 6%.
Even better for investors, Gilead is committed to returning at least half of its free cash flow each year to stockholders. In 2025, including its dividend distributions, Gilead returned 63% of its annual free cash flow to shareholders.
Despite its large size and established position, Gilead has continued to grow. In Q4 2025, it beat analyst expectations for both earnings per share and revenue, supported by legacy products and a strong pipeline. In 2026, the company expects at least four major commercial rollouts of new products, which should help maintain a diversified portfolio.
Gilead does face significant competition in the biopharma space, particularly in oncology—an area some investors would like to see gain a larger share of sales. Still, a large majority of Wall Street analysts have assigned bullish ratings to GILD shares, and analysts see roughly 6% more upside potential even after the stock's more than 28% gain over the past year.
Massive Dividend Growth Made Possible By Solid Cash Generation Power
Another major biopharma, AbbVie (NYSE: ABBV), posts a free cash flow yield above 5%, which is strong for a company of its size. While AbbVie markets therapeutics across many medical areas, one of the company's most attractive features for investors is its dividend.
AbbVie has a dividend yield that sits around 2.9% and has more than quadrupled its dividend distributions since going public more than a decade ago.
Although the company shows a high dividend payout ratio of 293%—a figure that may concern investors about the sustainability of its payouts—this level is supported by very strong free cash flow. In 2025, for example, AbbVie generated nearly $18 billion in free cash flow while paying about $11.7 billion in total dividends.
The company has demonstrated continued top-line and bottom-line growth, beating Wall Street expectations in Q4 2025 and issuing optimistic guidance for the future. This growth has been driven by two leading drugs, Skyrizi and Rinvoq, and the firm remains heavily invested in R&D to expand its pipeline.
Excellent Cash Generation Capacity Amid Consumer Resilience
Payments giant Visa Inc. (NYSE: V) operates a high-margin business that consistently generates substantial free cash flow, often converting half or more of its revenue into free cash flow in many quarters. With strong revenue performance—14.6% year-over-year growth in the latest period, for example—Visa is a reliable cash generator for investors.
Despite macro concerns such as tariffs and inflation, Visa's payments volume and processed transactions continue to rise, and consumer spending has proven resilient. That resilience has allowed Visa to keep increasing its dividend, currently offering a yield of 0.83% while maintaining a manageable 25.1% payout ratio. Not surprisingly, analysts generally rate Visa shares as a Buy and see roughly 22% upside potential going forward.
As Investors Flee U.S. Equities, This Global ETF Is Outperforming
Author: Jordan Chussler. Posted: 3/2/2026.
Key Points
- Investors are distancing themselves from U.S. equities due to AI fatigue, high tech valuations, and concerns over U.S. trade policies and federal debt.
- As a result, global equities are seeing a resurgence, with equities in developed and emerging markets outperforming their U.S. counterparts.
- The Vanguard FTSE All-World ex-US ETF has outperformed the U.S. benchmarks this year and over the past six months, with gains of 9% and 17%, respectively.
- Special Report: [Sponsorship-Ad-6-Format3]
Since the start of the year, investors have been vacating U.S. stocks and exchange-traded funds (ETFs) in a broad-based, risk-off strategy that has benefited safe-haven assets like gold and silver, as well as global equities.
Much of that exodus can be attributed to a flight to safety, as investors grow increasingly bearish about tech's ever-expanding, AI-fueled capital expenditures and a sell-off in software stocks. That has helped equal-weight ETFs outperform their heavily tech-weighted counterparts in the early goings of 2026, as the market's rotation has bolstered defensive sectors like energy and utilities.
Buy This Stock Now (Ad)
In 2000, I warned Barron's that a popular dot-com stock was headed for trouble. It dropped 90%. Now I'm making the opposite call on that same company: buy it now. This stock has become the lifeblood of AI data centers, yet almost no one has caught the story. While the media focuses on AI chip wars, they've missed this company's essential role in building out data centers. Their hardware is so critical that a single building uses enough of it to stretch around the world eight times. If you own Nvidia, you might want to pivot. If you missed Nvidia, this is your second chance at the AI data center buildout happening worldwide.
See the under-the-radar play fueling AI data centersBut it's not just lofty tech valuations that are serving as catalysts. Investors are also reducing their exposure to U.S. assets because of President Donald Trump's unpredictable tariff policies, a struggling U.S. dollar, and concerns about the federal government's rapidly expanding debt load.
International equities, often out of the limelight, have exhibited strong performances amid the ongoing "Sell America" trade. Savvy investors are gradually looking overseas for stronger market prospects.
The ETF for Breaking up With U.S. Equities
One of those options is the Vanguard FTSE All-World ex-US ETF (NYSEARCA: VEU), which tracks the performance of the FTSE All-World ex-US Index—an index composed of roughly 2,200 stocks of companies based in 46 countries, representing both the developed world and emerging markets around the globe.
Institutional ownership helps illustrate the popularity of the ex-U.S. trade—and the VEU in particular. Over the past 12 months, institutional buyers contributed more than $6 billion in inflows, nearly three times the just-over-$2 billion withdrawn by institutional sellers.
Another clue: current short interest is minuscule at 1.6%, or less than 12 million shares out of nearly 736 million shares outstanding.
That is, at least in part, due to the VEU's strong recent performance.
Year-to-date, the fund has gained more than 9% versus the S&P 500's slight gain of around 1%. And the VEU's outperformance has been even more pronounced over the past six months, with the ETF gaining nearly 17% against the S&P 500's 7%.
A Basket of Well-Diversified Global Holdings
For investors looking to maximize global diversification, the Vanguard FTSE All-World ex-US ETF delivers. While 14.7% of the fund's holdings are in companies based in Japan, it also boasts sizable representation in the United Kingdom (8.2%), Canada (7.3%), Taiwan (6%), Switzerland (5.3%), France (5.2%), and Germany (5.1%). The remaining 30.6% of the portfolio is spread across 39 countries.
Regarding sector exposure, the ETF skews heavily toward financials at nearly 25%, with technology (16.6%), industrials (12.1%), consumer discretionary (10.2%), and materials (7.5%) following behind.
While some investors may be hesitant because of the fund's "ex-U.S." label, many of the companies in the VEU's portfolio are household names. They include holdings such as Canada-based Shopify (NASDAQ: SHOP), U.K.-based drugmaker AstraZeneca (NASDAQ: AZN), Taiwan Semiconductor Manufacturing (NYSE: TSM), Swiss pharma firm Novartis (NYSE: NVS), and Chinese e-commerce giant Alibaba Group (NYSE: BABA), among other familiar large-cap companies.
Looking Under the VEU's Hood
The Vanguard FTSE All-World ex-US ETF receives an aggregate rating of Moderate Buy based on 43 analyst ratings of its companies over the past year.
With nearly $61 billion in assets under management, the fund is highly liquid with an average daily trading volume of 4.24 million shares.
With a net expense ratio of 0.04%, the ETF's fees are lower than what shareholders pay for the passively managed SPDR S&P 500 ETF Trust (NYSEARCA: SPY), which has a net expense ratio of 0.09%. And over the past six months, VEU has produced roughly 10 percentage points more in gains than SPY.
At around $81 per share, the VEU is trading near the top of its 52-week range. However, given the macro environment and the ongoing "Sell America" trade, there are reasons to believe this fund may continue to outperform as the market rotates away from U.S. equities and into international names.
This email message is a paid advertisement sent on behalf of Priority Gold, a third-party advertiser of MarketBeat. Why was I sent this email?.
If you need assistance with your newsletter, please email our U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC.
345 N Reid Place #620, Sioux Falls, SD 57103. United States of America..
No comments:
Post a Comment